ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

75 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q1 2021.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 43.3M shares of 105M outstanding shares and own 41.12% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (6.42M shares), FMR LLC (4.75M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.69M shares), WELLINGTON MANAGEMENT GROUP LLP (3.39M shares), GOLDMAN SACHS GROUP INC (3.31M shares), JENNISON ASSOCIATES LLC (2.6M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.12M shares), RA CAPITAL MANAGEMENT, L.P. (2.12M shares), CITIGROUP INC (1.89M shares), and Point72 Asset Management, L.P. (1.52M shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.